Oz Healthcare Communications appointed by Novartis 12 Feb 200812 Feb 2008 WhatsappPrintPDFXLinked-inFacebookMore sharing optionsOz Healthcare Communications have added another account to their portfolio of global pharmaceutical brands with the addition of Aclasta (zoledronic acid) from Novartis.